These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
714 related items for PubMed ID: 16669606
1. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods. Kuhns MC, Busch MP. Mol Diagn Ther; 2006; 10(2):77-91. PubMed ID: 16669606 [Abstract] [Full Text] [Related]
2. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Busch MP. Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546 [Abstract] [Full Text] [Related]
3. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing. van de Laar TJ, Hogema BM, Molenaar-de Backer MW, Marijt-van der Kreek T, Zaaijer HL. Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233 [Abstract] [Full Text] [Related]
4. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group. Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857 [Abstract] [Full Text] [Related]
5. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus? Niederhauser C, Mansouri Taleghani B, Graziani M, Stolz M, Tinguely C, Schneider P. Swiss Med Wkly; 2008 Mar 08; 138(9-10):134-41. PubMed ID: 18330733 [Abstract] [Full Text] [Related]
6. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA. Transfusion; 2005 Aug 08; 45(8):1247-57. PubMed ID: 16078909 [Abstract] [Full Text] [Related]
7. Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection? Dodd RY, Nguyen ML, Krysztof DE, Notari EP, Stramer SL. Transfusion; 2018 Sep 08; 58(9):2166-2170. PubMed ID: 30144082 [Abstract] [Full Text] [Related]
8. Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015). Fiedler SA, Oberle D, Chudy M, Scheiblauer H, Henseler O, Halbauer J, Heiden M, Funk M. Vox Sang; 2019 Jul 08; 114(5):443-450. PubMed ID: 31012114 [Abstract] [Full Text] [Related]
9. Detection of hepatitis B virus infection in German blood donors 2008-2015. Scheiblauer H, Heiden M, Funk M, Oberle D, Kreß J, Jork C, Chudy M. Vox Sang; 2020 Apr 08; 115(3):152-161. PubMed ID: 32023664 [Abstract] [Full Text] [Related]
10. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY. Transfusion; 2012 Feb 08; 52(2):440-6. PubMed ID: 21810101 [Abstract] [Full Text] [Related]
11. Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance programme covering more than 30 million donations in Germany. Houareau C, Offergeld R. Vox Sang; 2019 Jul 08; 114(5):459-466. PubMed ID: 30968958 [Abstract] [Full Text] [Related]
12. Significance of HBV NAT Among HBs Antigen-Negative Blood Donors in Saudi Arabia. Alabdallat NG, Bin Dukhyil AAA. Lab Med; 2018 Oct 11; 49(4):342-346. PubMed ID: 29767761 [Abstract] [Full Text] [Related]
13. Donor screening for hepatitis B virus infection in a cell and tissue bank. Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ. Transpl Infect Dis; 2008 Dec 11; 10(6):391-5. PubMed ID: 18665905 [Abstract] [Full Text] [Related]
14. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection. Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NAT Study Group. Transfusion; 2014 Aug 11; 54(8):2084-91. PubMed ID: 24650170 [Abstract] [Full Text] [Related]
15. NAT for HBV and anti-HBc testing increase blood safety. Roth WK, Weber M, Petersen D, Drosten C, Buhr S, Sireis W, Weichert W, Hedges D, Seifried E. Transfusion; 2002 Jul 11; 42(7):869-75. PubMed ID: 12375659 [Abstract] [Full Text] [Related]
16. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. O'Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC. Transfusion; 2007 Oct 11; 47(10):1809-15. PubMed ID: 17880605 [Abstract] [Full Text] [Related]
18. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations. Martin LA, Stramer SL, Kuhns MC, Schlauder GG. Transfusion; 2012 Oct 11; 52(10):2201-8. PubMed ID: 22321072 [Abstract] [Full Text] [Related]
19. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection. Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A. Indian J Med Res; 2006 Jan 11; 123(1):37-42. PubMed ID: 16567866 [Abstract] [Full Text] [Related]
20. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Hennig H, Puchta I, Luhm J, Schlenke P, Goerg S, Kirchner H. Blood; 2002 Oct 01; 100(7):2637-41. PubMed ID: 12239179 [Abstract] [Full Text] [Related] Page: [Next] [New Search]